ArticleBMC oral health2026
Customized pharmacological approach to acute and post-operative dental pain control in Iran: guideline review and adaptation.
Article in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundFormulating a tailored clinical practice guideline is imperative for each country, necessitated by the refined considerations of medication availability, accessibility, and affordability. Hence, in this study, we aimed to investigate the clinical practice guidelines regarding acute and postoperative dental pain and customize them in prescribing analgesics for Iranian general dentists.
methodsThe study employed a two-phase approach; a qualitative customization of dental pain management guidelines and a cross-sectional analytic phase. The qualitative phase involved assembling a panel of specialists and adapting existing guidelines to create customized flowcharts, along with a review of literature regarding relative guidelines. In the cross-sectional analytic phase, two questionnaires (one for each flowchart) were designed to build a consensus-based final guideline for Iranian dentists. Participants provided insights through questionnaires, assessing relevance and clarity. The Scale content validity index (S-CVI) and item content validity index (I-CVI) were assessed, with a threshold of 0.79 considered acceptable.
resultsOur search initially identified 763 articles and guidelines. After screening, 36 studies provided recommended strategies for acute dental and post-operative pain management. According to these studies and the available regimens in Iran, pain management was outlined in two flowcharts, A and B, addressing mild, moderate and severe pain levels. The lowest Item-level content validity index (I-CVI) was 0.93 and all items showed acceptable agreement regarding content validity. Scale-level content validity index (S-CVI) values reached 0.99 for flowchart A and B., indicating strong consensus among experts. Also, since all items showed acceptable agreement and were above the threshold value, the S-CVI/UA for the relevance and clarity in both flowcharts A and B were 100% among all experts in our study.
conclusionsAcetaminophen and ibuprofen are the drug of choice for dental pain. For more intense dental and post-operative dental pains a combination of these two drugs or their combination with opioids is recommended. In Iran, the only available opioid is codeine 10–20 mg that is combined with acetaminophen 300–325 mg, which is prescribed for severe dental pains. Naproxen can also be an effective alternative to ibuprofen.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.